Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.

Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.

<p><strong>Objectives:</strong> Recruitment to pragmatic trials is often difficult, and little is known about factors associated with key participation and treatment decisions. These were explored in the Prostate cancer testing and Treatment (ProtecT) study.</p> <...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Donovan, JL, Opmeer, B, Young, GJ, Mills, N, Martin, RM, Lane, JA, Metcalfe, C, Peters, TJ, Davis, M, Turner, EL, Walsh, E, Neal, DE, Hamdy, FC, ProtecT Study Group
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Elsevier 2019

Παρόμοια τεκμήρια

A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
ανά: Donovan, JL, κ.ά.
Έκδοση: (2017)

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
ανά: J. Donovan, κ.ά.
Έκδοση: (2003-01-01)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
ανά: Young, GJ, κ.ά.
Έκδοση: (2017)

Addressing patient treatment preferences at trial recruitment.
ανά: Mills, N, κ.ά.
Έκδοση: (2011)

Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
ανά: Lane, A, κ.ά.
Έκδοση: (2016)

Exploring treatment preferences facilitated recruitment to randomized controlled trials
ανά: Mills, N, κ.ά.
Έκδοση: (2011)

Exploring treatment preferences facilitated recruitment to randomized controlled trials.
ανά: Mills, N, κ.ά.
Έκδοση: (2011)

Factors distinguishing general practitioners who more readily participated in a large randomized trial were identified.
ανά: Down, L, κ.ά.
Έκδοση: (2009)

Addressing patient treatment preferences at trial recruitment
ανά: Mills Nicola, κ.ά.
Έκδοση: (2011-12-01)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
ανά: Donovan, J, κ.ά.
Έκδοση: (2003)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
ανά: Harrison, S, κ.ά.
Έκδοση: (2020)

The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation
ανά: Rooshenas, L, κ.ά.
Έκδοση: (2018)

A comparison of socio-demographic and psychological factors between patients consenting to randomisation and those selecting treatment (the ProtecT study).
ανά: Mills, N, κ.ά.
Έκδοση: (2006)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
ανά: Turner, E, κ.ά.
Έκδοση: (2011)

Radiotherapy for prostate cancer: is it 'what you do' or 'the way that you do it'? A UK perspective on technique and quality assurance.
ανά: Mason, MD, κ.ά.
Έκδοση: (2016)

Low risk research using routinely collected identifiable health information without informed consent: encounters with the Patient Information Advisory Group.
ανά: Metcalfe, C, κ.ά.
Έκδοση: (2008)

Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of participatory and informed consent (PIC)
ανά: Wade, J, κ.ά.
Έκδοση: (2017)

Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial.
ανά: Walsh, E, κ.ά.
Έκδοση: (2016)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
ανά: Avery, K, κ.ά.
Έκδοση: (2007)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
ανά: Down, L, κ.ά.
Έκδοση: (2011)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
ανά: Avery, K, κ.ά.
Έκδοση: (2008)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
ανά: Macefield, R, κ.ά.
Έκδοση: (2009)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
ανά: Down, L, κ.ά.
Έκδοση: (2011)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
ανά: Lane, J, κ.ά.
Έκδοση: (2010)

Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
ανά: Hamdy, FC, κ.ά.
Έκδοση: (2023)

ProDiet: A phase II randomized placebo-controlled trial of green tea catechins and lycopene in men at increased risk of prostate cancer
ανά: Lane, JA, κ.ά.
Έκδοση: (2018)

Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: The CAP randomized clinical trial
ανά: Martin, RM, κ.ά.
Έκδοση: (2018)

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY
ανά: Collin, S, κ.ά.
Έκδοση: (2009)

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.
ανά: Hamdy, F, κ.ά.
Έκδοση: (2003)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
ανά: Lane, J, κ.ά.
Έκδοση: (2007)

Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer
ανά: Donovan, J, κ.ά.
Έκδοση: (2016)

Understanding and improving recruitment to randomised controlled trials: Qualitative research approaches.
ανά: Elliott, D, κ.ά.
Έκδοση: (2017)

A review of reporting of participant recruitment and retention in RCTs in six major journals
ανά: Tomlin Zelda, κ.ά.
Έκδοση: (2009-07-01)

Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protecT randomised controlled trial according to treatment received
ανά: Neal, D, κ.ά.
Έκδοση: (2019)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
ανά: Simpkin, A, κ.ά.
Έκδοση: (2013)

Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
ανά: Rosario, D, κ.ά.
Έκδοση: (2008)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
ανά: Collin, S, κ.ά.
Έκδοση: (2009)

Polygenic prediction of occupational status GWAS elucidates genetic and environmental interplay in intergenerational transmission, careers and health in UK Biobank
ανά: Akimova, ET, κ.ά.
Έκδοση: (2024)

Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of Participatory and Informed Consent (PIC)
ανά: Julia Wade, κ.ά.
Έκδοση: (2017-07-01)

Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
ανά: Williams, N, κ.ά.
Έκδοση: (2011)